The Epithelioid Hemangioendothelioma (EHE) Foundation and Cleveland Clinic recently received a $1 million gift from the Margie and Robert E. Petersen Foundation. The money will support EHE research conducted by Brian Rubin, MD, PhD, Chair of the Robert J. Tomsich Pathology & Laboratory Medicine Institute and a member of the Cancer Biology Program of Cleveland Clinic’s Lerner Research Institute. The Petersen Foundation has also agreed to match an additional $1 million in research funding if The EHE Foundation can raise its own $1 million over the next 3 years.
EHE is an unpredictable, rare, vascular cancer. Similar to many other cancers, it is caused by a genetic malfunction that encodes a unique cancer-causing protein. Dr. Rubin and his colleagues are studying this protein to discover vulnerabilities that can be exploited therapeutically. ■
